WebPioneering change to diagnose, treat, modify, and prevent inflammation-driven diseases including dementia, early Alzheimer's and cardio-metabolics Keystone Bio brings Biotech, Medicine, and Dentistry together to shut down systemic inflammation. WebJenthera Therapeutics Inc. 290 followers on LinkedIn. We are a CRISPR gene editing platform company, correcting and disrupting genes to develop ground-breaking therapeutics. Jenthera...
Phil Roche - CERASP Scientific.. - Jenthera Therapeutics ZoomInfo
WebOct 21, 2024 · The company's platform offers a novel cell-targeted nuclease approach for therapeutics that addresses the fundamental challenges faced by CRISPR-based gene editing, enabling healthcare clients with immunogenicity, safety, and cost-effective products. Contact Information Website www.jenthera.com Ownership Status Privately Held (backing) Web#News: We are incredibly proud and honoured to announce that this equity investment from the Ontario Brain Institute (OBI) will fund our preclinical work… 80裁缝攻略
Jenthera Therapeutics - Overview, News & Competitors - ZoomInfo
WebToronto Innovation Centre. MaRS Centre, West Tower 661 University Ave., Suite 405 Toronto, Ontario, Canada M5G 1M1. T. 416.673.8100 WebPhilip Roche is Director of Jenthera Therapeutics Inc.. Discover digital health profiles, team, funding and valuation with HealthTech Alpha. Philip Roche Jenthera Therapeutics Inc. … WebAt Trepso Therapeutics, we’re developing a therapy to relieve pain, regenerate tissue, and restore function and quality of life in those suffering from degenerative disc and articular joint diseases. Trepso’s dual-mechanism therapy treats both the symptoms and the underlying pathology of disc and joint damage. 80裁缝洗布地点